VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd, marking a significant step in VTL's distribution strategy into the market of the People's Republic of China.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II clinical study in Pancreatic Cancer.
Anatara Lifesciences (ASX:ANR) is pleased to invite shareholders, investors and interested parties to an online Webinar on the Company's Stage 1 Irritable Bowel Syndrome (IBS) clinical trial results, hosted by Chair, Dr. David Brookes.
VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2022.
American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease
Fiji Kava Ltd (ASX:FIJ), a health and wellness company with operations in Australia, Fiji, and the USA, provides shareholders the following update on the acquisition of Leilo Inc. USA.
